
Moderna prepares a combined vaccine against covid, flu and respiratory syncytial virus
23 March, 2022Salary tables 2022
23 March, 2022A study carried out in the United Kingdom and published in the journal 'JAMA Neurology' warns of two new signs related to this disease that more than 5.000 Aragonese suffer from.
Parkinson's: "Neurological disorder, generally typical of elderly people, characterized by slowness of voluntary movements, muscle weakness and rigidity, and rhythmic tremor of the limbs." This is the definition given by the Royal Academy of the Language to an illness that Currently in Spain it affects "about 160.000 people", according to data from the Spanish Society of Neurology (SEN), of which more than 5.000 are Aragonese.
Taking into account that, as the SEN points out, The number of people affected by Parkinson's will triple in Spain in 2050, investigating the symptoms and detecting possible early signs is essential for faster diagnosis.
This is what researchers at Queen Mary University of London, who have just published in the journal 'JAMA Neurology' a study on the "two new alarm signals" -as defined in the same report-, which are hearing loss and epilepsy.
In contrast, new research carried out in United Kingdom provides further evidence on symptoms, using data from a diverse urban population for the first time. For the sample, the electronic primary medical care records of over a million people living in east London between 1990 and 2018 to explore early symptoms that could be related to the disease.
One result, that of this study, "that must be checked over time and based on the evolution of each patient"says Miguel García, president of the Aragonese Society of Family and Community Medicine. "Parkinson's is a disease that has treatment to slow down the symptoms of the disease itself, but that there is no cure. It is true that epilepsy or lack of hearing can be new signs, but there is a risk of not diagnosing the patient correctly if these are not associated with other signs of the illness," comments the doctor.
For its part, from the Parkinson's Association of Aragon They assure that the research carried out by Queen Mary University of London "is very interesting and positive." "We support any type of investment, study and research that is related to the disease, issues necessary to understand its development and evolution.", they point out from the entity.
"We also consider the voluntary collaboration of patients in this type of study to be important. In our case, whenever it has been necessary we have offered to help both in the programs of the Miguel Servet Hospital as in the San Jorge University of Zaragoza"conclude the same sources.
Source: Heraldo de Aragón